Loading...
Eupraxia Pharmaceuticals (EPRXF, $4.35) was one of top quarterly gainers, jumping +4 to $4.35 per share. A.I.dvisor analyzed 960 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down.
Industry Biotechnology